Get started
Author

Toshiyuki Tenma

ORCID: 0009-0003-1209-661X
Observed ORCID: 0009-0003-1209-661X
OpenAlex ID: A5002638562
RNA sensing induced by chromosome missegregation augments anti-tumor immunity
2024 · Nobunari Sasaki, Mizuki Homme, et al. · Molecular Cell · 31
Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024
2022 · Satoshi Oizumi, Kei Takamura, et al. · International Journal of Clinical Oncology · 16
Viability and diagnostic potential of tissues obtained through cryobiopsy
2024 · Ryotaro Kida, Ryohei Yoshida, et al. · Respiratory Investigation · 5
Detection of resistance mutations in patients with anaplastic lymphoma kinase-rearranged lung cancer through liquid biopsy
2023 · Takaaki Sasaki, Ryohei Yoshida, et al. · Translational Lung Cancer Research · 4
PDF
Afatinib Versus Osimertinib for Non‐Small Cell Lung Cancer With Uncommon EGFR Mutations: Real‐World Outcomes
2026 · Yutaro Nagano, Hiroshi Yokouchi, et al. · Cancer Science · 2
Case Report: Case series: association between blood concentration and side effects of sotorasib
2023 · Ryota Shigaki, Ryohei Yoshida, et al. · Frontiers in Oncology · 2
Acute eosinophilic pneumonia following inhalation of turpentine oil: A case report
2020 · Yasuhiro Umekage, Shunsuke Okumura, et al. · Respiratory Medicine Case Reports · 1
PDF
Afatinib versus osimertinib for non–small cell lung cancer with uncommon epidermal growth factor receptor mutations: Real-world outcomes (HOT-Next001/HOT2501).
2026 · Yutaro Nagano, Hiroshi Yokouchi, et al. · Journal of Clinical Oncology
Data from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure 1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure 2 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Table S1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure S1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure S4 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure 4 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure S3 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure S2 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Figure 3 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al.
Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025 · Toshiyuki Tenma, Ryohei Yoshida, et al. · Cancer Research Communications
Works count: 19
Citation count: 61
H-index: 4
I10-index: 2
Year
Topic
Type